U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C14H25N3O9.ClH
Molecular Weight 415.824
Optical Activity UNSPECIFIED
Defined Stereocenters 10 / 10
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of KASUGAMYCIN HYDROCHLORIDE

SMILES

Cl.[H][C@]2(O[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O)O[C@H](C)[C@H](C[C@@H]2N)NC(=N)C(O)=O

InChI

InChIKey=ZDRBJJNXJOSCLR-NZXABURVSA-N
InChI=1S/C14H25N3O9.ClH/c1-3-5(17-12(16)13(23)24)2-4(15)14(25-3)26-11-9(21)7(19)6(18)8(20)10(11)22;/h3-11,14,18-22H,2,15H2,1H3,(H2,16,17)(H,23,24);1H/t3-,4+,5+,6-,7+,8+,9-,10+,11+,14-;/m1./s1

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C14H25N3O9
Molecular Weight 379.363
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 10 / 10
E/Z Centers 0
Optical Activity UNSPECIFIED

Kasugamycin, an aminoglycoside antibiotic, potently inhibits both gram-positive and gram-negative bacteria, binds to the 30S subunit of the bacterial ribosome, and suppresses protein synthesis. Kasugamycin was studied in clinical use for urinary tract infections due to Pseudomonas aeruginosa and was investigated its therapeutic effect on respiratory infections due to Pseudomonas aeruginosa. Experiments in vitro showed that kasugamycin did not have any appreciable effect against a variety of bacteria tested. The only exceptions were several species of gram-negative bacteria, against which antibiotics that are more satisfactory already exist. That is why further evaluation of kasugamycin for potential human use as an antipseudomonal was discontinued.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: bacterial 30S ribosome
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Unknown

Approved Use

Unknown
Curative
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Increased sensitivity to protein synthesis inhibitors in cells lacking tmRNA.
2001 Dec
Establishment of a new cross of the rice blast fungus derived from Japanese differential strain Ina168 and hermaphroditic rice pathogen Guy11.
2001 Jul
Coordination mode and reactivity of copper(II) complexes with kasugamycin.
2001 Jun
Continuous culture of immobilized streptomyces cells for kasugamycin production.
2001 May-Jun
Requirement for SAPK-JNK signaling in the induction of apoptosis by ribosomal stress in REH lymphoid leukemia cells.
2003 Nov
Drug resistance in Chromobacterium violaceum.
2004 Mar 31
Crystal structure of KsgA, a universally conserved rRNA adenine dimethyltransferase in Escherichia coli.
2004 May 28
New media for the semiselective isolation and enumeration of Xanthomonas campestris pv. mangiferaeindicae, the causal agent of mango bacterial black spot.
2005
DNA sequencing and transcriptional analysis of the kasugamycin biosynthetic gene cluster from Streptomyces kasugaensis M338-M1.
2006 Jan
Antibiotic blocks mRNA path on the ribosome.
2006 Oct
The antibiotic kasugamycin mimics mRNA nucleotides to destabilize tRNA binding and inhibit canonical translation initiation.
2006 Oct
Structural analysis of kasugamycin inhibition of translation.
2006 Oct
Structure of the chloroplast ribosome: novel domains for translation regulation.
2007 Aug
Experimental characterization of Cis-acting elements important for translation and transcription in halophilic archaea.
2007 Dec
Acidic pH shock induces the expressions of a wide range of stress-response genes.
2008 Dec 16
Sequence and structural evolution of the KsgA/Dim1 methyltransferase family.
2008 Oct 29
Global transcriptional response to mammalian temperature provides new insight into Francisella tularensis pathogenesis.
2008 Oct 8
ksgA mutations confer resistance to kasugamycin in Neisseria gonorrhoeae.
2009 Apr
An unexpected type of ribosomes induced by kasugamycin: a look into ancestral times of protein synthesis?
2009 Jan 30
Less is more for leaderless mRNA translation.
2009 Jan 30
Isolation and activity of Xenorhabdus antimicrobial compounds against the plant pathogens Erwinia amylovora and Phytophthora nicotianae.
2009 Sep
Analysis of antibiotic fungicide kasugamycin in irrigation water by high performance liquid chromatography.
2010 Jul
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
The median minimal inhibitory concentration (MIC) of the Pseudomonas strains tested was 250 mug/ml and the bactericidal level was 500 mug/ml. Kasugamycin was found to be slightly more active in a more basic medium (Mycin Assay broth) in which the median MIC for 11 Pseudomonas strains was 125 mug/ml. Kasugamycin manifests a modest degree of serum binding. Kasugamycin did not have any appreciable effect against a variety of bacteria tested. The only exceptions were several species of gram-negative bacteria, against which more satisfactory antibiotics already exist.
Substance Class Chemical
Created
by admin
on Sat Dec 16 02:13:53 GMT 2023
Edited
by admin
on Sat Dec 16 02:13:53 GMT 2023
Record UNII
SXA18D440T
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
KASUGAMYCIN HYDROCHLORIDE
Common Name English
D-CHIRO-INOSITOL, 3-O-(2-AMINO-4-((CARBOXYIMINOMETHYL)AMINO)-2,3,4,6-TETRADEOXY-.ALPHA.-D-ARABINO-HEXOPYRANOSYL)-, HYDROCHLORIDE (1:1)
Common Name English
KASUMIN
Common Name English
Code System Code Type Description
CAS
19408-46-9
Created by admin on Sat Dec 16 02:13:53 GMT 2023 , Edited by admin on Sat Dec 16 02:13:53 GMT 2023
PRIMARY
MESH
C100305
Created by admin on Sat Dec 16 02:13:53 GMT 2023 , Edited by admin on Sat Dec 16 02:13:53 GMT 2023
PRIMARY
ALANWOOD
kasugamycin hydrochloride
Created by admin on Sat Dec 16 02:13:53 GMT 2023 , Edited by admin on Sat Dec 16 02:13:53 GMT 2023
PRIMARY
EPA CompTox
DTXSID2040739
Created by admin on Sat Dec 16 02:13:53 GMT 2023 , Edited by admin on Sat Dec 16 02:13:53 GMT 2023
PRIMARY
FDA UNII
SXA18D440T
Created by admin on Sat Dec 16 02:13:53 GMT 2023 , Edited by admin on Sat Dec 16 02:13:53 GMT 2023
PRIMARY
Related Record Type Details
SOLVATE->ANHYDROUS
Related Record Type Details
ACTIVE MOIETY